Response time for ecallantide treatment of acute hereditary angioedema attacks

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 6, 2010, Pages

  Riedl, Marc ^a   Campion, Marilyn ^b   Horn, Patrick T ^c   Pullman, William E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Consultant ^*  (United States)

^c Dyax Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECALLANTIDE; PLACEBO;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 78649905266     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.09.005     Document Type: Article

References (14)

1. A. Agostoni, and M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine 71 1992 206 215
2. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
3. F. Bracho Hereditary angioedema Curr Opin Hematol 12 2005 493 498
4. B.L. Zuraw Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new? Ann Allergy Asthma Immunol 100 2008 S13 S18
5. A.E. Davis C1 inhibitor and hereditary angioneurotic edema Ann Rev Immunol 6 1988 595 628
6. J.H. Levy, and P.S. O'Donnell The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema Expert Opin Investig Drugs 15 2006 1077 1090
7. L. Schneider, W. Lumry, A. Vegh, A.H. Williams, and T. Schmalbach Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor J Allergy Clin Immunol 120 2007 416 422
8. M.M. Gompels, R.J. Lock, and M. Abinun C1 inhibitor deficiency: consensus document Clin Exp Immunol 139 2005 379 394
9. K. Bork, P. Staubach, A.J. Eckardt, and J. Hardt Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency Am J Gastroenterol 101 2006 619 627
10. K. Bork, and S.E. Barnstedt Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema Arch Intern Med 161 2001 714 718
11. K. Bork, G. Meng, P. Staubach, and J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
12. K. Bork, P. Staubach, and J. Hardt Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema Allergy 63 2008 751 757
13. T.J. Craig, R.J. Levy, and R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
14. A.T. Waytes, F.S. Rosen, and M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634